S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: World markets are lower after China unveils 5% economic growth target for 2024
Critical asset just had biggest fall on record (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: World markets are lower after China unveils 5% economic growth target for 2024
Critical asset just had biggest fall on record (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: World markets are lower after China unveils 5% economic growth target for 2024
Critical asset just had biggest fall on record (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: World markets are lower after China unveils 5% economic growth target for 2024
Critical asset just had biggest fall on record (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Closing prices for crude oil, gold and other commodities

Feedback (FDBK) Competitors

GBX 104
+6.50 (+6.67%)
(As of 05:56 AM ET)

FDBK vs. TRLS, INHC, IQAI, COG, RENX, ABDX, BVX, BSFA, MXC, and SNG

Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Trellus Health (TRLS), Induction Healthcare Group (INHC), IQ-AI (IQAI), Cambridge Cognition (COG), Renalytix (RENX), Abingdon Health (ABDX), BiVictriX Therapeutics (BVX), BSF Enterprise (BSFA), MGC Pharmaceuticals (MXC), and Synairgen (SNG). These companies are all part of the "medical" sector.

Feedback vs.

Trellus Health (LON:TRLS) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, community ranking, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Feedback's return on equity of -29.34% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus HealthN/A -29.34% -17.82%
Feedback N/A -32.67%-21.47%

Feedback has higher revenue and earnings than Trellus Health. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£35K135.67-£7.54M£0.01294.00
Feedback£1.02M13.59-£3.49M-£0.26-400.00

13.5% of Trellus Health shares are held by institutional investors. Comparatively, 52.8% of Feedback shares are held by institutional investors. 57.5% of Trellus Health shares are held by company insiders. Comparatively, 11.0% of Feedback shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Feedback had 1 more articles in the media than Trellus Health. MarketBeat recorded 1 mentions for Feedback and 0 mentions for Trellus Health. Trellus Health's average media sentiment score of 0.40 beat Feedback's score of 0.00 indicating that Feedback is being referred to more favorably in the news media.

Company Overall Sentiment
Trellus Health Neutral
Feedback Neutral

Feedback received 165 more outperform votes than Trellus Health when rated by MarketBeat users.

CompanyUnderperformOutperform
Trellus HealthN/AN/A
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trellus Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Feedback
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Trellus Health has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.

Summary

Feedback beats Trellus Health on 7 of the 13 factors compared between the two stocks.


Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FDBK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£13.86M£233.90M£4.93B£1.33B
Dividend Yield4.56%6.12%5.34%12.11%
P/E Ratio-400.00592.99196.621,701.43
Price / Sales13.59914.373,008.29434,920.12
Price / Cash1.1237.0432.5032.83
Price / Book1.557.134.482.50
Net Income-£3.49M-£6.18M£112.52M£178.20M
7 Day Performance53.48%2.58%1.16%0.33%
1 Month Performance52.38%6.59%12.58%0.64%
1 Year Performance-41.57%-4.29%13.12%28.27%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
0 of 5 stars
GBX 3.75
flat
N/A-49.1%£6.06M£35,000.00375.0031
INHC
Induction Healthcare Group
0 of 5 stars
GBX 16
-5.9%
N/A-28.4%£14.78M£11.82M-106.6783Gap Down
IQAI
IQ-AI
0 of 5 stars
GBX 1.75
+2.9%
N/A-45.4%£3.45M£538,190.00-13.676
COG
Cambridge Cognition
0 of 5 stars
GBX 51.50
flat
N/A-55.5%£18.00M£12.77M-468.1880
RENX
Renalytix
0 of 5 stars
GBX 28.50
+8.6%
N/A-64.0%£28.48M£2.41M-79.17102
ABDX
Abingdon Health
0 of 5 stars
GBX 7.75
flat
N/A+38.9%£9.43M£4.04M-775.0082
BVX
BiVictriX Therapeutics
0 of 5 stars
GBX 11.50
flat
N/AN/A£9.49MN/A-287.5017Gap Down
BSFA
BSF Enterprise
0 of 5 stars
GBX 8.75
flat
N/A-46.5%£9.04MN/A-437.5012
MXC
MGC Pharmaceuticals
0 of 5 stars
GBX 20.50
flat
N/AN/A£8.99M£3.39M-5.57N/AGap Down
SNG
Synairgen
0 of 5 stars
GBX 5.03
-0.6%
N/A-53.6%£10.12M£79,000.00-100.5530Gap Down

Related Companies and Tools

This page (LON:FDBK) was last updated on 3/5/2024 by MarketBeat.com Staff